Methylcobalamin

Structure

Methylcobalamin (CH3-B12) is one of the two physiologically active coenzyme forms of vitamin B12. Its structure centers on a corrin ring with cobalt (Co) held at the center. The key difference from cyanocobalamin (the pharmaceutical/supplement form) is the substituent attached to cobalt: a methyl group (-CH3) replaces the cyanide (-CN) group. The other active coenzyme form, 5'-deoxyadenosylcobalamin, carries a deoxyadenosine group instead.

Structure of cobalamin forms - Lippincott's Biochemistry, 8th ed.

Biochemical Roles

Methylcobalamin has one primary enzymatic role:

1. Methionine Synthase Reaction (Methyl Transfer)

Methylcobalamin serves as a cofactor for methionine synthase, the enzyme that converts homocysteine to methionine. The methyl group is donated by N5-methyltetrahydrofolate (CH3-THF), which passes it to cobalamin forming methylcobalamin, which then transfers it to homocysteine to produce methionine.

Cyclic diagram showing methylcobalamin in the methionine synthase reaction: N5-methyltetrahydrofolate donates a methyl group to cobalamin forming methylcobalamin, which converts homocysteine to methionine, regenerating tetrahydrofolate

Methyl transfer cycle - Katzung's Basic & Clinical Pharmacology, 16th ed.

This reaction is critical because:

It regenerates tetrahydrofolate (THF) from the trapped N5-methyl form
It produces methionine and subsequently S-adenosylmethionine (SAM), the universal methyl donor for numerous methylation reactions
It links folate metabolism to B12 metabolism (the "folate trap" mechanism)

2. Folate Trap (Consequences of Deficiency)

When methylcobalamin is deficient, N5-methyl-THF cannot be demethylated. Folate becomes "trapped" in this unusable form, starving cells of the THF derivatives (N5,N10-methylene-THF, N10-formyl-THF) needed for purine and thymidylate synthesis. This impairs DNA replication in rapidly dividing cells - most notably erythroid precursors in bone marrow and intestinal epithelium - causing megaloblastic anemia.

"The methionine synthetase reaction is largely responsible for the control of the recycling of folate cofactors... and through the synthesis of methionine and its product S-adenosylmethionine (SAM), the maintenance of a number of methylation reactions." - Goodman & Gilman's, 13th ed.

Methylcobalamin vs. Adenosylcobalamin

Feature	Methylcobalamin	5'-Deoxyadenosylcobalamin
Location	Cytoplasm	Mitochondria
Enzyme	Methionine synthase	Methylmalonyl-CoA mutase
Reaction	Homocysteine → Methionine	L-methylmalonyl-CoA → Succinyl-CoA
Deficiency marker	Elevated homocysteine	Elevated methylmalonic acid (MMA)
Clinical relevance	Megaloblastic anemia, neuropathy	Organic acidemia (methylmalonic aciduria)

Methylcobalamin vs. Cyanocobalamin

	Methylcobalamin	Cyanocobalamin
Naturally occurring	Yes (in food, plasma, CSF)	No (synthetic)
Active form	Yes - directly usable	No - requires hepatic conversion
CNS penetration	Better	Limited
Storage	Lower	More stable, longer shelf life
Conversion needed	None	Must be converted to methyl- or adenosyl-cobalamin
Preferred in	Neurological disease, malabsorption	Broad supplementation, fortified foods

Clinical Uses

Vitamin B12 deficiency - pernicious anemia, vegans, malabsorption states (gastric resection, Crohn's, metformin use)
Peripheral neuropathy - particularly diabetic peripheral neuropathy; commonly used in Asia (orally or IM)
Elevated homocysteine - hyperhomocysteinemia, reducing cardiovascular risk markers
Subacute combined degeneration of the spinal cord - demyelination of posterior and lateral columns due to B12 deficiency
Neuropathic pain - emerging use; reduces hyperpolarization-activated ion channel activity

Deficiency: Neurological Mechanism

The neurological complications of B12 deficiency (subacute combined degeneration) are thought to result from disruption of the methionine synthesis pathway rather than methylmalonyl-CoA accumulation. Disrupted SAM production impairs myelin synthesis and maintenance. Branched-chain fatty acids (from abnormal methylmalonyl-CoA metabolism via the adenosylcobalamin pathway) may also incorporate into CNS cell membranes, contributing to neurological damage.

"Folic acid in the setting of vitamin B12 deficiency will not prevent neurologic manifestations even though it will largely correct the anemia." - Katzung's Basic & Clinical Pharmacology, 16th ed.

This is a clinically important point: treating with folate alone can mask the anemia while neurological damage progresses silently.

Dosing & Administration

Dietary requirement (RDA): 2.4 mcg/day
Body stores: 2-5 mg (mostly in liver); deficiency symptoms may take 3-5 years to emerge after cessation of intake
Oral supplementation: 500-1,500 mcg/day (high-dose oral can bypass intrinsic factor deficiency via passive diffusion)
Intramuscular: 100-1,000 mcg/day to weekly; preferred in pernicious anemia and severe deficiency
Pernicious anemia maintenance: 100 mcg IM every 4 weeks for life

Recent Evidence

A 2025 systematic review and meta-analysis (PMID: 40612436) examined dapagliflozin combined with methylcobalamin for type 2 diabetes with peripheral neuropathy, finding the combination beneficial for neuropathy outcomes. A 2024 meta-analysis (PMID: 38330524) of disease-modifying therapies for diabetic peripheral neuropathy supports methylcobalamin as one of the more evidence-backed agents for this indication.

Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic & Clinical Pharmacology, 16th ed.; Lippincott's Illustrated Reviews: Biochemistry, 8th ed.; Tietz Textbook of Laboratory Medicine, 7th ed.

Dynapar qps

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Viveramn

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

Doli 650

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

This is a shared conversation. Sign in to Orris to start your own chat.